Literature DB >> 2923509

Anticardiolipin antibodies in systemic lupus erythematous.

N Snowden, P Wilson, R Pumphrey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2923509      PMCID： PMC1003682          DOI： 10.1136/ard.48.1.80-b

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  3 in total

1.  Anti-phospholipid antibodies in syphilis and a thrombotic subset of SLE: distinct profiles of epitope specificity.

Authors:  C B Colaço; D K Male
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

Review 2.  Anti-phospholipid antibodies.

Authors:  E N Harris; A E Gharavi; G R Hughes
Journal:  Clin Rheum Dis       Date:  1985-12

3.  IgG subclass and light chain distribution of anticardiolipin and anti-DNA antibodies in systemic lupus erythematosus.

Authors:  A E Gharavi; E N Harris; M D Lockshin; G R Hughes; K B Elkon
Journal:  Ann Rheum Dis       Date:  1988-04       Impact factor: 19.103
  3 in total
  4 in total

1.  Selective polyclonal increase of immunoglobulin G1 subclass: a link with Sjögren's syndrome.

Authors:  E M Hay; A J Freemont; R A Kay; R M Bernstein; P J Holt; R S Pumphrey
Journal:  Ann Rheum Dis       Date:  1990-06       Impact factor: 19.103

2.  IgG2 subclass restriction of anti-beta 2 glycoprotein 1 antibodies in autoimmune patients.

Authors:  J Arvieux; B Roussel; D Ponard; M G Colomb
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

3.  Immunoglobulin class and IgG subclass distribution of anticardiolipin antibodies in patients with systemic lupus erythematosus and associated disorders.

Authors:  S Loizou; C Cofiner; A P Weetman; M J Walport
Journal:  Clin Exp Immunol       Date:  1992-12       Impact factor: 4.330

4.  A prospective study of psychiatric disorder and cognitive function in systemic lupus erythematosus.

Authors:  E M Hay; A Huddy; D Black; P Mbaya; B Tomenson; R M Bernstein; P J Lennox Holt; F Creed
Journal:  Ann Rheum Dis       Date:  1994-05       Impact factor: 19.103
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.